The investigation from MethSurv (https://biit.cs.ut.ee/methsurv/) showed that BC patients with higher ZNF132 methylation had a shorter survival time (Fig. 6a; P = 1.802E-04). This evidence concerns the gene ZNF132 and breast cancer.